168 related articles for article (PubMed ID: 27252074)
1. The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.
Yang PM; Du JL; Wang GN; Chia JS; Hsu WB; Pu PC; Sun A; Chiang CP; Wang WB
Integr Cancer Ther; 2017 Sep; 16(3):319-328. PubMed ID: 27252074
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
[TBL] [Abstract][Full Text] [Related]
3. "Tien-Hsien liquid" can modulate antigen-stimulated cytokine production by T-cells isolated from patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Wang WB; Chiang CP
Am J Chin Med; 2005; 33(4):559-71. PubMed ID: 16173530
[TBL] [Abstract][Full Text] [Related]
4. The chinese herbal medicine Tien-Hsien liquid inhibits cell growth and induces apoptosis in a wide variety of human cancer cells.
Sun A; Chia JS; Chiang CP; Hsuen SP; Du JL; Wu CW; Wang WB
J Altern Complement Med; 2005 Apr; 11(2):245-56. PubMed ID: 15865490
[TBL] [Abstract][Full Text] [Related]
5. Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses.
Ma YH; Cheng WZ; Gong F; Ma AL; Yu QW; Zhang JY; Hu CY; Chen XH; Zhang DQ
World J Gastroenterol; 2008 Sep; 14(34):5274-81. PubMed ID: 18785279
[TBL] [Abstract][Full Text] [Related]
6. Polysaccharide from
Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
[TBL] [Abstract][Full Text] [Related]
7. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
8. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
9. Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.
Li Y; Yang F; Sang L; Zhu J; Han X; Shan F; Li S; Zhai J; Wang D; Lu C; Sun X
Oncol Rep; 2015 Oct; 34(4):1795-804. PubMed ID: 26238268
[TBL] [Abstract][Full Text] [Related]
10. Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function.
Chen X; Cao Z; Zhang Y; Li J; Wang S; Du J; Liao L
Integr Cancer Ther; 2017 Sep; 16(3):329-338. PubMed ID: 27335087
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
[TBL] [Abstract][Full Text] [Related]
13. IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production.
Jaime-Ramirez AC; Mundy-Bosse BL; Kondadasula S; Jones NB; Roda JM; Mani A; Parihar R; Karpa V; Papenfuss TL; LaPerle KM; Biller E; Lehman A; Chaudhury AR; Jarjoura D; Burry RW; Carson WE
J Immunol; 2011 Mar; 186(6):3401-9. PubMed ID: 21321106
[TBL] [Abstract][Full Text] [Related]
14. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.
Saudemont A; Jouy N; Hetuin D; Quesnel B
Blood; 2005 Mar; 105(6):2428-35. PubMed ID: 15536145
[TBL] [Abstract][Full Text] [Related]
15. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
16. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
17. Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation‑induced tumor growth.
Huang X; Qin J; Lu S
Mol Med Rep; 2014 Oct; 10(4):2153-9. PubMed ID: 25119060
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.
Zeytin H; Reali E; Zaharoff DA; Rogers CJ; Schlom J; Greiner JW
J Interferon Cytokine Res; 2008 Feb; 28(2):73-87. PubMed ID: 18279103
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor and immunomodulatory activity of peptide fraction from the larvae of Musca domestica.
Sun HX; Chen LQ; Zhang J; Chen FY
J Ethnopharmacol; 2014 May; 153(3):831-9. PubMed ID: 24690776
[TBL] [Abstract][Full Text] [Related]
20. An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3
Ferrari L; Martelli P; Saleri R; De Angelis E; Ferrarini G; Cavalli V; Passeri B; Bazzoli G; Ogno G; Magliani W; Borghetti P
Comp Immunol Microbiol Infect Dis; 2020 Oct; 72():101523. PubMed ID: 32758800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
